Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit UnionBynum, AL
07:59am, Tuesday, 02'nd Jun 2026
BIO-key Delivers Phishing-Resistant Biometric Security to Alabama's AOD Federal Credit Union via Strategic IT Solutions Partnership with Provider BlueAlly
A Look at Bio-Rad Laboratories Inc (BIO) After 4.2% Gain -- GF Value $318.25 vs Price $318.22
06:37pm, Thursday, 28'th May 2026
On May 28, 2026, Bio-Rad Laboratories Inc (BIO) shares rose 4.2% today, closing at a price of $318.22. The stock has shown significant performance over the last
Elliott Targets Bio-Rad After 70% Stock Collapse
12:25pm, Friday, 22'nd May 2026
Elliott Investment Management has reportedly built a sizable stake in Bio-Rad Laboratories (BIO), putting fresh activist pressure on a life-science tools suppli
VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME
04:38pm, Tuesday, 19'th May 2026
Cross-Agency Discussion Highlights Interest in Oral Formulation as Field-Deployable Medical Countermeasure SAN ANTONIO, May 19, 2026 /PRNewswire/ -- Valion Bio, Inc. (Nasdaq: VBIO), a late-stage inna
Bio-Rad Laboratories, Inc. (BIO) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
10:40am, Tuesday, 19'th May 2026
Bio-Rad Laboratories, Inc. (BIO) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
HOLMDEL, N.J., May 18, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, an
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports
09:38pm, Sunday, 17'th May 2026
Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories , and plans to push the company to boost its underperforming stock pr
Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad
08:03pm, Sunday, 17'th May 2026
Elliott also has a stake in German lab-equipment supplier Sartorius, where Bio-Rad is also an investor.
BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
04:15pm, Thursday, 14'th May 2026
KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fire
VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
04:05pm, Thursday, 14'th May 2026
First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration of Velocity Bioworks Conference Call to be Hel
HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today
Biometric Identity and Authentication Provider BIO-key to host Q1'26 Investor Webcast Monday, May 18th at 10am ET
07:59am, Tuesday, 12'th May 2026
HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host
Bio-Rad to Participate in Upcoming Investor Conferences
09:00am, Friday, 08'th May 2026
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will p
Initial Study to Evaluate Entolimod™ for Gastrointestinal Tissue Preservation in Partial-Body Acute Radiation Syndrome — an Indication for Which No Currently Approved or Stockpiled Countermeasure
Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects
10:16am, Monday, 04'th May 2026
Explore how Bio-Rad's (BIO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
